Magnite See’s 6% Revenue Growth in 2023 Q4

Photo of author
Written By Keziah Monique Gayo

Magnite, Inc. (MGNI), a leading provider of online advertising solutions, specializes in automating the purchase and sale of digital advertising inventory, particularly in TV and mobile advertisements.

The company’s revenue model hinges on a take rate percentage from the total digital advertisement budget.

With a significant portion of its business in the United States, accounting for approximately 75% of its total revenue as of FY23, MGNI witnessed revenue growth of 6% in the fourth quarter of 2023, propelled by a 17% increase in mobile revenue.

This growth translated into an impressive gross margin expansion from 29% to 58%, elevating gross profit from $46 million to $95 million and turning a negative EBIT margin into a positive 21% in 4Q23.

The Disney Deal and its Implications

A major point of discussion surrounding MGNI is its deal with Disney (DIS) concerning the new DRAX Direct product.

This product integrates CTV and video ad inventory from Disney+ and Hulu for direct bidding through The Trade Desk’s OpenPath and Google’s DB360. Critics argue this arrangement might sideline MGNI, potentially stifling its growth due to its substantial exposure to TV ads.


However, analysts counter this pessimism by highlighting MGNI’s critical role in powering DRAX, supplying both the technology stack and engineering expertise.

This partnership not only underscores MGNI’s indispensability to Disney but also promises MGNI a more stable revenue stream that is less susceptible to fluctuations in advertising budgets.

Read More: Ballard Power’s Stock Soars Following Strategic European Deal and US Tax Credit Windfall

Magnite’s Strategic Position in the CTV Ecosystem

MGNI’s dominance in the CTV space is undisputed, being recognized as the largest CTV Supply-Side Platform (SSP) globally. This stature is crucial for attracting further clientele, thanks to the flywheel effect, where data accumulation enhances algorithmic efficiency and reduces costs.

Moreover, the integration of MGNI’s programmatic ad tools and its ownership of both a supply-side platform and an ad server fortify its value proposition to clients, evidenced by the significant uptake of its services among streaming partners.

Growth Catalysts and Market Opportunities

Looking ahead, MGNI is positioned to capitalize on several growth catalysts. The eventual streaming of live sports presents a significant opportunity, given live sports’ ability to attract dedicated viewerships. MGNI’s Live Sports Acceleration product, coupled with its extensive partnerships with major broadcasters and cable operators, places it at the forefront of this emerging trend.

Additionally, Amazon’s introduction of an ad tier for Prime TV is set to benefit MGNI, given its role in monetizing a substantial portion of the CTV ad inventory for broadcast and cable shows on Prime Video.

Also Read: Chemours Remains Resilient in The Face of Challenges

Valuation and Market Perception

Despite the stock’s recent downturn, attributed to concerns over the Disney deal, the valuation presents a compelling case. MGNI’s stock is deemed undervalued, trading at a discount compared to its adtech peers.

The market’s apprehension regarding the Disney partnership overlooks MGNI’s foundational role in this collaboration and its potential for recurring revenue.

As MGNI continues to demonstrate growth and resilience, it is expected that the market will adjust its valuation, aligning it closer to historical multiples and the broader adtech sector.

Risks and Considerations

While the outlook remains optimistic, risks persist, particularly regarding the Disney deal’s long-term economic implications and the broader macroeconomic environment’s impact on advertising spend.

A downturn could see companies reducing their marketing budgets, potentially affecting MGNI’s growth trajectory.


Despite the challenges posed by the Disney deal and market volatility, MGNI remains a strong buy. Its pivotal role in the advertising ecosystem, especially within the CTV domain, combined with significant growth catalysts, positions MGNI for future success.

The current valuation offers an attractive entry point, with expectations for a market reevaluation based on MGNI’s performance and strategic importance.

Read Next: Gain Therapeutics Welcomes New Chief Medical Officer


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at; the Financial Industry Regulatory Authority (the "FINRA") at, and relevant State Securities Administrator website and the OTC Markets website at The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: and

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.